Chemed (NYSE:CHE) Posts Quarterly Earnings Results, Misses Expectations By $0.12 EPS

Chemed (NYSE:CHE) issued its quarterly earnings results on Tuesday. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12), Briefing.com reports. The company had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. Chemed’s revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.32 earnings per share. Chemed updated its FY24 guidance to $23.00-$23.15 EPS and its FY 2024 guidance to 23.000-23.150 EPS.

Chemed Stock Down 0.9 %

CHE traded down $4.92 during midday trading on Friday, hitting $535.32. 128,505 shares of the company traded hands, compared to its average volume of 84,868. The company’s 50-day moving average is $586.09 and its 200 day moving average is $568.84. The firm has a market capitalization of $8.06 billion, a PE ratio of 27.32, a price-to-earnings-growth ratio of 2.18 and a beta of 0.44. Chemed has a 52 week low of $525.36 and a 52 week high of $654.62.

Insider Activity at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $569.63, for a total value of $1,139,260.00. Following the transaction, the chief executive officer now owns 105,735 shares of the company’s stock, valued at approximately $60,229,828.05. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, EVP Nicholas Michael Westfall sold 1,713 shares of Chemed stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $569.35, for a total transaction of $975,296.55. Following the sale, the executive vice president now owns 6,109 shares of the company’s stock, valued at approximately $3,478,159.15. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Monday, August 5th. The shares were sold at an average price of $569.63, for a total transaction of $1,139,260.00. Following the transaction, the chief executive officer now directly owns 105,735 shares of the company’s stock, valued at $60,229,828.05. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,144 shares of company stock worth $4,141,679 over the last quarter. Company insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.